Simultaneous assessment of regional adrenergic activity and perfusion with123I-MIBG and201T1 in congestive heart failure

Nuclear Medicine Communications

Volumn 17, Issue 3, 1996, Pages 225-230

  Seto, H ^a   Shimizu, M ^a   Nozawa, T ^a   Yoshida, N ^a   Inagaki, S ^a   Kageyama, M ^a   Kakishita, M ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADRENERGIC ACTIVITY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART MUSCLE BLOOD FLOW; HEART SCINTISCANNING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE;

3-IODOBENZYLGUANIDINE; ADULT; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIUM; NOREPINEPHRINE; REGRESSION ANALYSIS; THALLIUM RADIOISOTOPES; TISSUE DISTRIBUTION;

EID: 0029878042     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199603000-00009     Document Type: Article

References (24)

1. Wieland DM, Wu J-L, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH. Radiolabeled adrenergic neuron blocking agents: Adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med 1980; 21: 349-353.
2. Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu J-L, Clinthome NH et al. Myocardial imaging with a radioiodinated norepinephrine storage analogue. J Nucl Med 1981; 22: 22-31.
3. Sisson JC, Frager MS, Valk TW, Gross MD, Swanson, DP, Wieland, DM. et al. Scintigraphic localization of pheochromocytoma. N Engl J Med 1981; 305: 12-17.
4. Valk TW, Frager MS, Gross MD, Sisson JC, Wieland DM, Swanson DP et al. Spectrum of pheochromocytoma in multiple endocrine neoplasia: A scintigraphic portrayal using 1311-metaiodobenzylguanidine. Ann Intern Med 1981; 94: 762-767.
5. Kline RC, Swanson DP, Wieland MD, Thrall JH, Gross MD, Pitt B et al. Myocardial imaging in man with 1-123 meta-iodobenzylguanidine. J Nucl Med 1981; 22: 129-132.
6. Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986; 73: 913-919.
7. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-823.
8. Chidsey CA, Braunwald E, Morrow AG. Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am J Med 1965; 39: 442-451.
9. Swedberg K, Viquerat C, Rouleau JL, Roizen M, Atherton B, Parmley WW et al. Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. AmJ Cardiol 1984; 54: 783-786.
10. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986; 73: 615-621.
11. Handerson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkami P et al. Abnormal 1-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy Circulation 1988; 78: 1192-1199.
12. Schofer J, Spielmann R, Schubert A, Weber K, Schluter M. Iodine-123 metaiodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988; 12: 1252-1258.
13. 123I-metaiodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy Am Heart J 1990; 119: 1329-1337.
14. Merlet P, Dubis-Rande J-L, Adnot S, Bourguignon MG, Benventic C, Loisance D et al. Myocardial S-adrenergic desensitization and normal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 1992; 19: 10-16.
15. Ravinovitch MA, Rose CP, Schwab AJ, Fichett DH, Honos GN, Stewart LF et al. A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med 1993; 34: 589-600.
16. Nakajo M, Shapiro B, Glowniak J, Sisson JC, Beierwaltes WH. Inverse relationship between cardiac accumulation of meta-131-iodobenzylguanidine (1-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. J Nucl Med 1983; 24: 1127-1134.
17. Strauss HW, Harrison K, Pitt B. Thallium-201: Noninvasive determination of the regional distribution of cardiac output. J Nucl Med 1977; 18: 1167-1170.
18. 1 on fractional distribution of cardiac output and organ blood flow in man: A simultaneous and non-invasive determination using double dose thallium-201 scintigraphy. Cardiovasc Res 1984; 18: 657-662.
19. Asanoi H, Wada O, Miyagi K, Ishizaki S, Kameyama T, Seto H et al. New redistribution index of nutritive blood flow to skeletal muscle during dynamic exercise. Circulation 1992; 85: 1457-1463.
20. Seto H, Kageyama M, Shimizu M, Nagayoshi T, Futatsuya R, Kakishita M. Effect of ionic and nonionic contrast media on regional distribution of thallium-201 in rabbits. Radiat Med 1995; 13: 19-22.
21. Nakajo M, Shimabukuro K, Yoshimura H, Yonekura R, Nakabeppu Y, Tanoue P et al. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med 1986; 27: 84-89.
22. Esler M, Jennings G, Leonard P, Sachartas N, Burk F, Johns J et al. Contribution of individual organs to total nonadrenaline release in humans. Acta Physiol Scand 1984; 527 (suppl.): 11-16.
23. Fen QP, Carlsson S, Thoren P, Hedner T. Effects of clonidine on renal sympathetic nerve activity, natriuresis and diuresis in chronic congestive heart failure rats. J Pharmacol Exp Ther 1992; 261: 1129-1135.
24. Merlet P, Valette H, Dubois-Rande J-L, Moyse D, Duboc D, Dove P et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33: 471-477.